insights_auto
Why is PTGX up 2.73%?
Dive Deeperchevron_right
PTGX:NASDAQ
Protagonist Therapeutics Inc
$143.73
arrow_upward
+2.73%(+3.82) 1D
$143.00
arrow_downward
-0.51% (-0.73)bedtimeAfter hours
Closed: Oct 9, 4:00:00 PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for PTGX...
Open
$139.91
High
$146.30
Low
$138.95
Mkt. cap
9.30B
Avg. vol.
714.90K
Volume
763.10K
P/E ratio
138.59
52-wk high
$160.81
52-wk low
$65.77
EPS
$1.04
Beta
1.53
Shares outstanding
64.71M
No. of employees
141
Open
$139.91
High
$146.30
Low
$138.95
Mkt. cap
9.30B
Avg. vol.
714.90K
Volume
763.10K
P/E ratio
138.59
52-wk high
$160.81
52-wk low
$65.77
EPS
$1.04
Beta
1.53
Shares outstanding
64.71M
No. of employees
141
News stories
From web sources and news partners
MarketBeat
·
4 minutes ago
Protagonist Therapeutics (NASDAQ:PTGX) Stock Rating Cut to "Buy" at Wall Street Zen
https://www.dars.gov.et/
·
2 days ago
PTGX Q2 2026 Earnings: EPS Beats Consensus by 7.83% as Shares Edge Higher - Revenue Breakdown Analysis
About Protagonist Therapeutics Inc
CEO-
Employees141
Founded2006
HeadquartersNewark, California, United States
SectorBiotechnology
Websiteprotagonist-inc.com